Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning
Jeannine S. McCune(City of Hope), Paul J. Martin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Saurabh Chhabra(Medical College of Wisconsin), Khalid Bo-Subait(Medical College of Wisconsin), Amer Beitinjaneh(University of Miami), Jan Černý(Worcester Memorial Hospital), Joseph Bubalo(Oregon Health & Science University), Hillard M. Lazarus(University Hospitals of Cleveland), Jean‐Yves Cahn, L. Lee Dupuis(University of Toronto), Shin Mineishi(University of Alabama at Birmingham), Maxwell M. Krem(University of Kentucky), Richard T. Maziarz(Oregon Health & Science University), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Marcelo C. Pasquini(Cleveland Clinic), Tao Wang(Medical College of Wisconsin), Aaron Cumpston(West Virginia University Hospitals), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Tim Prestidge(Starship Children's Health)
Cited by 20
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k